You are here
PK Biosciences Corporation
UEI: LJK1DLPBXTB8
# of Employees: 1
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Preclinical evaluation of the anti-neuroinflammatory properties and pharmacokinetic profile of a novel Fyn kinase inhibitors
Amount: $224,912.00ABSTRACTParkinsonandapos s diseasePDis a debilitating neurodegenerative disorder characterized mainly by the progressive loss of dopaminergic neurons in the substantia nigra pars compactaSNpcresulting ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
Development of Novel Metformin Analog for Treatment of Parkinson's Disease
Amount: $331,967.00ABSTRACT of SBIR PproposalRNSFunded SepMore than a million Americans are afflicted with Parkinson s diseasePDa debilitating neurodegenerative disorderAs a result of a progressive and substantial loss ...
SBIRPhase I2018Department of Health and Human Services National Institutes of Health -
Development of Novel Neuroprotective Agents for Parkinson?s Disease
Amount: $153,440.00DESCRIPTION (provided by applicant): Parkinson's disease (PD) is a debilitating neurodegenerative disorder characterized by progressive and substantial loss of dopaminergic neurons in the substantia n ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health
